Dow Today: Merck (MRK) Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 94 points (+0.6%) at 16,654 as of Wednesday, Aug 13, 2014, 1:36 p.m. ET. During this time, 143.4 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 303.3 million. The NYSE advances/declines ratio sits at 2,238 issues advancing vs. 759 declining with 137 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Merck (NYSE: MRK), which is sporting a 70-cent gain (+1.2%) bringing the stock to $57.73. This single gain is lifting the Dow Jones Industrial Average by 5.3 points or roughly accounting for 5.6% of the Dow's overall gain. Volume for Merck currently sits at 5.4 million shares traded vs. an average daily trading volume of 8.2 million shares.

Merck has a market cap of $163.44 billion and is part of the health care sector and drugs industry. Shares are up 13.9% year-to-date as of Tuesday's close. The stock's dividend yield sits at 3.1%.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, growth in earnings per share and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications